Medicina, Dermatología y Toxicología
Departamento
![Foto de Medicina, Dermatología y Toxicología](/img/noimage.png)
![Foto de Hospital Morales Meseguer](/img/noimage_org.png)
Hospital Morales Meseguer
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Morales Meseguer (24)
2024
-
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245
2023
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
-
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas
2022
2021
-
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia
Blood, Vol. 137, Núm. 14, pp. 1879-1894
-
Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study
Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
-
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Blood, Vol. 138, Núm. 17, pp. 1583-1589
2019
-
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Leukemia, Vol. 33, Núm. 5, pp. 1256-1267
2018
-
Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia
Leukemia and Lymphoma, Vol. 59, Núm. 7, pp. 1634-1643
-
Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study
Critical Care, Vol. 22, Núm. 1
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
-
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy
British Journal of Haematology, Vol. 174, Núm. 6, pp. 859-867
2014
-
EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations
Revista Iberoamericana de Micologia, Vol. 31, Núm. 3, pp. 157-175
2012
-
Cost of clinical management of acromegaly in Spain
Clinical Drug Investigation, Vol. 32, Núm. 4, pp. 235-245
-
Pneumonia treated in the internal medicine department: Focus on healthcare-associated pneumonia
Clinical Microbiology and Infection, Vol. 18, Núm. 8, pp. 786-794
2011
-
Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus
Chest, Vol. 139, Núm. 3, pp. 555-562
-
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma
Leukemia, Vol. 25, Núm. 4, pp. 697-706
-
Impact of obesity in patients infected with 2009 influenza A(H1N1)
Chest, Vol. 139, Núm. 2, pp. 382-386
-
Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain
Respirology, Vol. 16, Núm. 1, pp. 78-85